What did COVID‐19 pandemics teach us about single‐fraction radiotherapy for painful bone metastases—State of the art or undertreatment?
Cancer Medicine · 2023
DOI: 10.1002/cam4.6231 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Tatjana Arsenijević und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Belgrade, Faculty of Medicine, Belgrade, Serbia. Hauptthemen laut MEDLINE: COVID-19, Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Choosing the optimal treatment approach for patients with painful bone metastases during the COVID‐19 pandemic became challenging. A simple technique, single fraction radiotherapy was recommended for these patients usually referring to bone metastases as a single entity, although it is a very heterogeneous group of patients.
Aim
This study aimed to analyze the response to palliative single fraction radiotherapy in relation to age, performance status, primary tumor, histopathology, and bone localization in the group of patients with painful bone metastases.
Methods
A clinical, prospective, non‐randomized study was conducted at the Institute for Oncology and Radiology of Serbia, which included 64 patients with noncomplicated, painful bone metastases who underwent palliative, pain‐relieving radiation therapy with a single tumor dose of 8Gy in a single hospital visit. Response to treatment was patient reported via telephone interview using visual analog scale. The response assessment was based on the international consensus panel of radiation oncologists.
Results
In the entire group of patients, 83% responded to radiotherapy. No statistically significant difference was observed in response to therapy, time to reach the maximum response, degree of pain reduction, nor in response duration depending on the patient's age, performance status, the primary origin of the tumor, histopathology, or location of the metastasis (bone) that was irradiated.
Conclusion
Regardless of clinical parameters, palliative radiotherapy with a single dose of 8Gy can be considered very effective in quick pain relief in patients with noncomplicated painful bone metastases. Single fraction radiotherapy in a single hospital visit, as well as patient‐reported outcome for these patients may be considered favorable beyond Covid pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Belgrade, Faculty of Medicine, Belgrade, Serbia.
- Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
ORCID-Profile: Tatjana Arsenijević, Aleksandar Stepanović
Zitieren
APA
Arsenijević, T., Stepanović, A., Milošević-Maračić, B., Poparić-Bandjur, B., Mišković, I., Gavrilović, D., & Nikitović, M. (2023). What did COVID‐19 pandemics teach us about single‐fraction radiotherapy for painful bone metastases—State of the art or undertreatment?. Cancer Medicine. https://doi.org/10.1002/cam4.6231
Vancouver
Arsenijević T, Stepanović A, Milošević-Maračić B, Poparić-Bandjur B, Mišković I, Gavrilović D, et al. What did COVID‐19 pandemics teach us about single‐fraction radiotherapy for painful bone metastases—State of the art or undertreatment?. Cancer Medicine. 2023. doi:10.1002/cam4.6231
BibTeX
@article{Arsenijevi2023,
author = {Arsenijević, Tatjana and Stepanović, Aleksandar and Milošević-Maračić, Brankica and Poparić-Bandjur, Bojana and Mišković, Ivana and Gavrilović, Dušica and Nikitović, Marina},
title = {What did COVID‐19 pandemics teach us about single‐fraction radiotherapy for painful bone metastases—State of the art or undertreatment?},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6231}
}
EUVIMED